Perfect Medical Health Management Limited (HKG:1830)

HKG:1830 Balance Sheet

Financials in millions HKD. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	141.1	249.07	567.4	439.19	444.6
Short-Term Investments	148.24	137.73	-	210.22	0.21
Cash & Short-Term Investments	289.34	386.8	567.4	649.41	444.81
Cash Growth	-25.20%	-31.83%	-12.63%	46.00%	-12.96%
Accounts Receivable	30.16	28.36	62.78	49.74	14.84
Other Receivables	2.09	3.49	0.51	0.59	1.15
Receivables	32.25	31.85	63.29	50.33	15.99
Inventory	5.24	13.96	6.45	8.91	5.87
Prepaid Expenses	9.54	10.96	20.36	12.1	18.88
Other Current Assets	19.37	28.03	39.65	31.54	22.54
Total Current Assets	355.73	471.61	697.15	752.29	508.09
Property, Plant & Equipment	202.78	315.48	407.73	409.33	552.6
Long-Term Investments	228.41	95.51	59.72	88.96	110.42
Long-Term Deferred Tax Assets	15.32	15.02	16.47	8.53	56.45
Other Long-Term Assets	31.96	38.29	40.75	37.19	53.63
Total Assets	834.2	935.91	1,222	1,296	1,281

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	2.36	0.86	1.07	0.84	1.59
Accrued Expenses	24.89	31.53	45.05	49.05	33.61
Current Portion of Leases	58.38	100.28	97.06	114.48	135.37
Current Income Taxes Payable	35.2	45.91	77.24	85.62	89.74
Current Unearned Revenue	193.69	197.45	260.81	252.07	236.68
Other Current Liabilities	21.15	23.21	35.59	18.73	25.9
Total Current Liabilities	335.66	399.24	516.82	520.79	522.9
Long-Term Leases	76.21	116.37	171.66	125.88	175.7
Long-Term Unearned Revenue	2.69	2.69	-	-	-
Long-Term Deferred Tax Liabilities	24.68	24.86	23.82	21.27	71.3
Other Long-Term Liabilities	7.1	14.03	12.7	16.09	17.03
Total Liabilities	446.34	557.18	725	684.02	786.93

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	125.62	125.62	125.62	125.65	124
Additional Paid-In Capital	194.37	194.37	263.46	336.46	329.16
Retained Earnings	117.54	124.72	208.01	213.45	104.91
Comprehensive Income & Other	-47.99	-64.76	-99.58	-63.29	-63.8
Total Common Equity	389.55	379.95	497.51	612.27	494.27
Minority Interest	-1.68	-1.22	-0.7	-	-
Shareholders' Equity	387.86	378.73	496.81	612.27	494.27
Total Liabilities & Equity	834.2	935.91	1,222	1,296	1,281

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	134.58	216.65	268.73	240.35	311.07
Net Cash (Debt)	154.75	170.15	298.68	409.06	133.74
Net Cash Growth	-9.05%	-43.03%	-26.98%	205.86%	-46.38%
Net Cash Per Share	0.12	0.14	0.24	0.33	0.11
Filing Date Shares Outstanding	1,256	1,256	1,256	1,257	1,240
Total Common Shares Outstanding	1,256	1,256	1,256	1,257	1,240
Working Capital	20.07	72.37	180.33	231.5	-14.8
Book Value Per Share	0.31	0.30	0.40	0.49	0.40
Tangible Book Value	389.55	379.95	497.51	612.27	494.27
Tangible Book Value Per Share	0.31	0.30	0.40	0.49	0.40
Land	20.4	16.52	16.52	16.52	16.52
Machinery	505.03	502.75	500.72	496.56	508.92
Leasehold Improvements	243.05	309.17	297.54	267.65	269.84

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 11, 2026

Data Sources Report a data error